Regulation of Pregnane X Receptor (PXR) Function and UGT1A1 Gene Expression by Posttranslational Modification of PXR Protein

被引:44
|
作者
Sugatani, Junko [1 ]
Uchida, Takahiro
Kurosawa, Masatoshi
Yamaguchi, Masahiko
Yamazaki, Yasuhiro
Ikari, Akira
Miwa, Masao
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacobiochem, Suruga Ku, Shizuoka 4228526, Japan
关键词
UDP-GLUCURONOSYLTRANSFERASE; 1A1; HEPATOCYTE GROWTH-FACTOR; NUCLEAR RECEPTORS; HEPG2; CELLS; TRANSCRIPTIONAL REGULATION; GLUCOCORTICOID-RECEPTOR; MEDIATED INDUCTION; ENHANCER MODULE; CAR; METABOLISM;
D O I
10.1124/dmd.112.046748
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human UDP-glucuronosyltransferase (UGT) 1A1 is a critical enzyme responsible for detoxification and metabolism of endogenous and exogenous lipophilic compounds such as bilirubin. The present study shows how cyclin-dependent kinase (CDK) inhibitor roscovitine stimulated the expression of UGT1A1 in HepG2 cells. Pregnane X receptor (PXR)-mediated transactivation of UGT1A1 reporter gene was more prominently enhanced by roscovitine, compared with the basal-, constitutive androstane receptor (CAR)-, and aryl hydrocarbon receptor-mediated activities. We determined the regulatory mechanism of UGT1A1 expression through PXR's stimulation by roscovitine. Although phosphomimetic mutations at Thr290 and Thr408 retained the PXR protein in cytoplasm and attenuated the induction of UGT1A1 expression by both roscovitine and rifampicin, a mutation at Ser350 specifically reduced the activity of PXR induced by roscovitine. Immunoprecipitation analysis revealed that the T290D but not T408D mutant protein remained in cytoplasm by forming a complex with heat shock protein 90 and cytoplasmic CAR retention protein, whereas treatment with proteasome inhibitor MG-132 accumulated the T408D mutant protein in cytoplasm. Transfection with anti-CDK2 small interfering RNA (siRNA) but not anti-CDK1 or CDK5 siRNA led to enhanced expression of UGT1A1. S350D yellow fluorescent protein-PXR fusion protein could translocate from cytoplasm to nucleus similar to the wild-type protein but was detected as an acetylated protein, whose binding with retinoid X receptor (RXR) and histone deacetylase was impaired. Cotransfection with coactivator steroid receptor coactivator (SRC) 2 but not SRC-1 partly recovered its PXR activity. These results indicate that roscovitine stimulated the expression of UGT1A1 by inhibiting CDK2, which phosphorylated PXR at Ser350 to suppress binding with RXR and coactivator and maintain the acetylation of PXR protein.
引用
收藏
页码:2031 / 2040
页数:10
相关论文
共 50 条
  • [31] Oleanolic Acid and Ursolic Acid Induce UGT1A1 Expression in HepG2 Cells by Activating PXR Rather Than CAR
    Yao, Na
    Zeng, Caiwen
    Zhan, Tao
    He, Fang
    Liu, Mingyi
    Liu, Fanglan
    Zhang, Hong
    Xiong, Yuqing
    Xia, Chunhua
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [32] The role of pregnane X receptor (PXR/NRli2) gene variants in inflammatory bowel disease
    Seiderer, Julia
    Glas, Juergen
    Diegelmann, Julia
    Fischer, Daniel
    Seitz, Barbara
    Tillack, Cornelia
    Pfennig, Simone
    Konrad, Astrid
    Wetzke, Martin
    Griga, Thomas
    Klein, Wolfram
    Epplen, Joerg T.
    Schiemann, Uwe
    Mussack, Thomas
    Lohse, Peter
    Goeke, Burkhard
    Ochsenkuehn, Thomas
    Folwaczny, Matthias
    Mueller-Myhsok, Bertram
    Brand, Stephan
    GASTROENTEROLOGY, 2008, 134 (04) : A457 - A457
  • [33] Regulation of the human UGT1 locus in a PXR-null mouse model
    Brace-Sinnokrak, Erin
    Tukey, Robert H.
    FASEB JOURNAL, 2008, 22
  • [34] High Pregnane-X-Receptor (PXR) expression is correlated with poor prognosis in invasive breast carcinoma
    Pouloudi, D.
    Giaginis, C.
    Gourzi, S.
    Alexandrou, P.
    Tsourouflis, G.
    Michail, A.
    Tsoukalas, N.
    Albesher, S.
    Politis, P.
    Nakopoulou, L.
    Theocharis, S.
    VIRCHOWS ARCHIV, 2019, 475 : S15 - S15
  • [35] RACIAL DIFFERENCES IN THE ASSOCIATION BETWEEN UGT1A1*28 AND GENE EXPRESSION OF UGT1A1 AND SEARCHING FOR NOVEL REGULATORY VARIANTS OF UGT1A1
    Montalvo, A.
    Ferber, J.
    Collins, J.
    Wang, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S76 - S77
  • [36] High Pregnane X Receptor (PXR) expression is associated with poor prognosis in patients with invasive breast carcinoma
    Theocharis, S.
    Giaginis, C.
    Gourzi, S.
    Tsourouflis, G.
    Danas, E.
    Nakopoulou, L.
    Alexandrou, P.
    VIRCHOWS ARCHIV, 2018, 473 : S53 - S53
  • [37] Regulation of bovine CYP3A28 promoter by pregnane X receptor (PXR) and constitutive androstane receptor (CAR)
    Giantin, M.
    Zancanella, V.
    Kueblbeck, J.
    Prantner, V.
    Sansonetti, F.
    Honkakoski, P.
    Dacasto, M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 : 54 - 55
  • [38] Importance of pregnane X receptor (PXR) and P-glycoprotein (MDR1) to tamoxifen response and endoxifen disposition
    Teft, Wendy A.
    Mansell, Sara E.
    Kim, Richard B.
    CANCER RESEARCH, 2011, 71
  • [39] Pregnane x receptor (PXR) interacts with the nuclear corepressor SMRT to repress basal CP3A4 gene expression.
    Johnson, DR
    Chen, L
    Li, JH
    Kupfer, D
    Chen, D
    TOXICOLOGICAL SCIENCES, 2003, 72 : 372 - 372
  • [40] Expression and regulation of UDP-glucuronosyltransferases from the UGT1A and UGT2B families in mice with altered PXR activity
    Radominska-Pandya, A
    Xie, W
    Heydel, JM
    DRUG METABOLISM REVIEWS, 2003, 35 : 56 - 56